Patent 7109326 was granted and assigned to Genentech on September, 2006 by the United States Patent and Trademark Office.
Halo-alkoxycarbonyl derivatives are provided as prodrug moieties for pharmaceutical agents containing a basic or polar nitrogen containing functionality. The prodrugs are provided as pharmaceutical compositions as well as in methods of treatment.